FI890072A0 - Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi

Info

Publication number
FI890072A0
FI890072A0 FI890072A FI890072A FI890072A0 FI 890072 A0 FI890072 A0 FI 890072A0 FI 890072 A FI890072 A FI 890072A FI 890072 A FI890072 A FI 890072A FI 890072 A0 FI890072 A0 FI 890072A0
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutically usable
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
FI890072A
Other languages
English (en)
Swedish (sv)
Other versions
FI90865C (fi
FI90865B (fi
FI890072A (fi
Inventor
Klaus Hasspacher
Reto Naef
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI890072A0 publication Critical patent/FI890072A0/fi
Publication of FI890072A publication Critical patent/FI890072A/fi
Application granted granted Critical
Publication of FI90865B publication Critical patent/FI90865B/fi
Publication of FI90865C publication Critical patent/FI90865C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FI890072A 1988-01-08 1989-01-06 Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi FI90865C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888800397A GB8800397D0 (en) 1988-01-08 1988-01-08 Improvements in/relating to organic compounds
GB8800397 1988-01-08

Publications (4)

Publication Number Publication Date
FI890072A0 true FI890072A0 (fi) 1989-01-06
FI890072A FI890072A (fi) 1989-07-09
FI90865B FI90865B (fi) 1993-12-31
FI90865C FI90865C (fi) 1994-04-11

Family

ID=10629678

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890072A FI90865C (fi) 1988-01-08 1989-01-06 Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi

Country Status (28)

Country Link
US (1) US4980359A (fi)
JP (1) JPH0649686B2 (fi)
KR (1) KR0142686B1 (fi)
AT (1) AT394365B (fi)
AU (1) AU622429B2 (fi)
BE (1) BE1002730A3 (fi)
CA (1) CA1332944C (fi)
CH (1) CH678727A5 (fi)
DE (1) DE3900233C2 (fi)
DK (1) DK5789A (fi)
ES (1) ES2010071A6 (fi)
FI (1) FI90865C (fi)
FR (1) FR2625743B1 (fi)
GB (2) GB8800397D0 (fi)
GR (1) GR1002750B (fi)
HU (1) HU205083B (fi)
IE (1) IE61914B1 (fi)
IL (1) IL88899A (fi)
IT (1) IT1229523B (fi)
LU (1) LU87423A1 (fi)
MY (1) MY103963A (fi)
NL (1) NL8900029A (fi)
NZ (1) NZ227561A (fi)
PH (1) PH25640A (fi)
PL (1) PL156099B1 (fi)
PT (1) PT89405B (fi)
SE (1) SE501548C2 (fi)
ZA (1) ZA89133B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723674A (en) * 1951-11-28 1955-11-15 Charles E Harris Telephone cableman's tent
US3007541A (en) * 1959-02-24 1961-11-07 Jr John B Mast Temporary covering and support structure therefor
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
BR9107169A (pt) * 1990-12-17 1993-11-16 Shell Int Research Derivados de isoquinolina fungicidas
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5350423A (en) * 1992-09-23 1994-09-27 Burlington Industries Inc. Fabric finishing procedure
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
CZ297045B6 (cs) * 1994-12-23 2006-08-16 Smithkline Beecham Corporation Hlodavcí neutralizacní monoklonální protilátka, zpusob pro její produkci, kompozice s jejím obsahema pouzití, hybridom a jím produkovaná protilátka,fab fragment, komplementaritu urcující region, molekula nukleové kyseliny a její sekvence, plasmid a
US7399837B2 (en) * 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
IT1296985B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
US6534518B1 (en) 1999-01-15 2003-03-18 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
JP5038568B2 (ja) 1999-08-21 2012-10-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 協力剤の組合せ物
BRPI0409229A (pt) 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
ES2492943T3 (es) * 2007-04-30 2014-09-10 Glaxosmithkline Llc Procedimientos de administración de anticuerpos anti-IL5
BRPI0910854A2 (pt) * 2008-03-28 2015-10-06 Glaxosmithkline Llc métodos de tratamento
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.
WO2018226339A1 (en) 2017-06-06 2018-12-13 Glaxosmithkline Llc Biopharmaceutical compositions and methods for pediatric patients

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
DE1184344B (de) * 1962-06-16 1964-12-31 Orgamol Sa Verfahren zur Herstellung von Isochinolinderivaten
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
DE2401453A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
SE7500859L (fi) * 1974-02-05 1975-08-06 Sandoz Ag
DE2811361A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinaldehyde und verfahren zu ihrer herstellung
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
CA1330560C (en) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Di- and tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
ZA89133B (en) 1990-09-26
CA1332944C (en) 1994-11-08
SE8900039D0 (sv) 1989-01-05
DK5789A (da) 1989-07-09
GB8800397D0 (en) 1988-02-10
KR0142686B1 (ko) 1998-07-15
ES2010071A6 (es) 1989-10-16
FR2625743B1 (fr) 1990-11-09
GR890100008A (el) 1994-03-31
SE501548C2 (sv) 1995-03-13
DE3900233C2 (de) 2000-04-27
JPH01213267A (ja) 1989-08-28
PT89405B (pt) 1993-09-30
IT8947504A0 (it) 1989-01-04
GB2213482A (en) 1989-08-16
AT394365B (de) 1992-03-25
ATA3589A (de) 1991-09-15
US4980359A (en) 1990-12-25
DE3900233A1 (de) 1989-07-20
SE8900039L (sv) 1989-07-09
PL156099B1 (pl) 1992-02-28
CH678727A5 (fi) 1991-10-31
HU205083B (en) 1992-03-30
FI90865C (fi) 1994-04-11
MY103963A (en) 1993-10-30
DK5789D0 (da) 1989-01-06
FI90865B (fi) 1993-12-31
GB8900102D0 (en) 1989-03-01
AU622429B2 (en) 1992-04-09
PH25640A (en) 1991-08-21
IE890037L (en) 1989-07-08
KR890011851A (ko) 1989-08-22
GB2213482B (en) 1991-09-11
NL8900029A (nl) 1989-08-01
IT1229523B (it) 1991-09-04
AU2779589A (en) 1989-07-20
PT89405A (pt) 1990-02-08
GR1002750B (el) 1997-08-26
NZ227561A (en) 1991-11-26
IL88899A0 (en) 1989-08-15
FI890072A (fi) 1989-07-09
IL88899A (en) 1994-07-31
FR2625743A1 (fr) 1989-07-13
LU87423A1 (fr) 1989-08-30
JPH0649686B2 (ja) 1994-06-29
HUT52061A (en) 1990-06-28
IE61914B1 (en) 1994-11-30
BE1002730A3 (fr) 1991-05-21
PL277092A1 (en) 1989-09-04

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890072A (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI905941A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
HU895305D0 (en) Process for the preparation of piperidinyl-benzimidazole derivatives
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
PT86687A (pt) Process for the preparation of novel polyamine derivatives
FI95570C (fi) Menetelmä lääkinnällisesti vaikuttavien pyridatsinoni-3(2H)-onijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
HU895410D0 (en) Process for the preparation of quinolyl-oxazol-2-on derivatives
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI893003A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO172844C (no) Fremgangsmaate for fremstilling av syntesegass
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI892420A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
PT87359A (pt) Process for the preparation of pyrrolidine derivatives

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG